If you’ve been on a sleep medication for more than a few months and started asking whether it’s actually safe to keep taking, you’re not alone. The doxepin vs trazodone question comes up constantly, partly because both drugs get prescribed off-label for insomnia, and partly because neither one is a controlled substance like zolpidem or temazepam.
That feels reassuring on the surface. Non-controlled, older, well-studied. But "old and familiar" isn’t the same thing as "safe forever," and the long-term picture for these two drugs is genuinely different.
Here’s what a pharmacist would walk you through at the counter if you had fifteen minutes and a real question about which one to stay on.
What Doxepin and Trazodone Actually Do
Both are technically antidepressants. Both are used at much lower doses for sleep than for depression. That’s where the similarity ends.
Doxepin is a tricyclic antidepressant. At sleep doses (typically 3 to 6 mg), it works almost entirely as a histamine H1 blocker, which is what makes you drowsy. The low-dose formulation is FDA-approved specifically for sleep maintenance insomnia, meaning trouble staying asleep rather than falling asleep.
Trazodone is a serotonin modulator. It’s FDA-approved for depression at doses of 150 to 600 mg per day, but the vast majority of trazodone prescriptions written in the US are for sleep, off-label, at 25 to 100 mg. The American Academy of Sleep Medicine’s 2017 clinical practice guideline actually recommends against using trazodone for chronic insomnia in most adults because the evidence base is thin compared to drugs studied at sleep-specific doses.
That’s the first big asymmetry in the doxepin vs trazodone comparison. One is approved for sleep. The other is borrowed from the depression toolbox.
Side Effect Profiles That Matter Long-Term
Short-term, both drugs feel similar to a lot of patients: drowsy, slightly groggy in the morning, dry mouth, maybe a bit of next-day fog. The longer-term picture is where they diverge.
Doxepin at low doses (3 to 6 mg):
- Very few anticholinergic effects at sleep doses, despite being a tricyclic
- Minimal effect on blood pressure or heart rhythm at 6 mg or less
- No documented dependence or tolerance in trials up to 3 months
- Can worsen narrow-angle glaucoma and urinary retention even at low doses
Doxepin at higher doses (anything above 25 mg):
- Anticholinergic load goes up sharply: confusion, constipation, urinary retention
- QT prolongation becomes a real concern
- Listed on the Beers Criteria as potentially inappropriate for adults 65 and older at doses above 6 mg
Trazodone for sleep (typically 25 to 100 mg):
- Morning grogginess is the most common complaint, more so than with low-dose doxepin
- Orthostatic hypotension, meaning dizziness on standing, especially in older adults
- Rare but real risk of priapism in men (roughly 1 in 6,000)
- QT prolongation at higher doses
- Also flagged by Beers Criteria for use in older adults, mainly because of fall risk
The fall-risk piece is the one that quietly causes the most harm. Trazodone-associated falls in older adults are well-documented in nursing-home data, and a hip fracture at 78 changes the trajectory of someone’s life more than the insomnia ever did.
Which Drug Causes Fewer Long-Term Problems
For most healthy adults under 65, the doxepin vs trazodone comparison tilts toward low-dose doxepin if the goal is sleep maintenance and the dose stays at or below 6 mg. The evidence base is cleaner. The side effect load is lower. There’s no controlled-substance status and no meaningful tolerance issue in trials.
Trazodone has a place. If someone has comorbid depression, anxiety, or PTSD-related sleep disruption, trazodone at 50 to 100 mg can do double duty in a way doxepin really can’t. Patients with restless legs sometimes do better on trazodone too.
But "double duty" cuts both ways. If you’re taking trazodone purely for sleep, you’re accepting the serotonergic side effect profile, the orthostatic hypotension risk, and the small but non-zero priapism risk for a benefit that low-dose doxepin probably delivers more cleanly.
For a broader look at how trazodone stacks up against another common sleep antidepressant, our piece on trazodone vs mirtazapine for sleep walks through that head-to-head in detail.
Special Populations Where This Matters
Older adults. Both drugs carry Beers Criteria warnings, but low-dose doxepin (3 mg and 6 mg specifically) is the exception explicitly carved out. Above 6 mg, doxepin becomes problematic. Trazodone at any dose carries the fall-risk flag.
Patients on other serotonergic drugs. SSRIs, SNRIs, tramadol, triptans. Trazodone adds to serotonergic load and the rare risk of serotonin syndrome. Doxepin is cleaner here.
Patients with cardiac disease. Both can prolong QT, but trazodone at sleep doses is generally lower risk than doxepin at antidepressant doses. At low sleep doses of doxepin, cardiac risk is minimal.
Patients with dementia or mild cognitive impairment. Anticholinergic exposure is linked to worse cognition over time. If you’re already thinking about cognitive risk, our discussion of warning signs to watch for with dementia medications like donepezil is worth a look. The same anticholinergic concern shows up across drug classes.
If you’re weighing controlled vs non-controlled sleep options more broadly, the comparison of suvorexant vs zolpidem for long-term insomnia safety covers the newer orexin-receptor antagonists, which are an increasingly common alternative to both doxepin and trazodone.
Cost and Access
Both drugs are generic and inexpensive. Generic doxepin capsules and the brand Silenor (3 mg and 6 mg tablets) differ in price quite a bit, with Silenor running noticeably higher. Generic trazodone is one of the cheaper psychotropic prescriptions on the market. You can compare current generic doxepin and trazodone pricing at edrugstore.com if cost is part of your decision.
The Bottom Line on Doxepin vs Trazodone
For long-term sleep use, low-dose doxepin generally has the safer profile, particularly for adults over 65 and for anyone without coexisting depression. Trazodone remains a reasonable choice when depression or anxiety travels with the insomnia, but the fall risk, orthostatic effects, and serotonergic interactions need to be weighed. The honest answer in the doxepin vs trazodone debate is that the "safer" drug depends on your other diagnoses, your other medications, and your age. Ask your prescriber or pharmacist to look at your full medication list before you commit to either one for the long haul.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA prescribing information for low-dose doxepin (Silenor), official FDA-approved indication and dosing for sleep maintenance insomnia.
- American Academy of Sleep Medicine 2017 Clinical Practice Guideline for Chronic Insomnia, evidence-based recommendation against routine use of trazodone for chronic insomnia.
- American Geriatrics Society 2023 Updated Beers Criteria, guidance on potentially inappropriate medication use in older adults, including doxepin and trazodone.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More